Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02047747
Title A Phase II Study of Dacomitinib in Progressive Brain Metastases
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors David Piccioni, M.D., Ph.D
Indications

lung cancer

breast cancer

melanoma

stomach cancer

Therapies

Dacomitinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.